DK111748B - Fremgangsmåde til fremstilling af 3β-hydroxy- eller -acyloxy-Δ<5(10)>-steroider. - Google Patents
Fremgangsmåde til fremstilling af 3β-hydroxy- eller -acyloxy-Δ<5(10)>-steroider.Info
- Publication number
- DK111748B DK111748B DK197363A DK197363A DK111748B DK 111748 B DK111748 B DK 111748B DK 197363 A DK197363 A DK 197363A DK 197363 A DK197363 A DK 197363A DK 111748 B DK111748 B DK 111748B
- Authority
- DK
- Denmark
- Prior art keywords
- acyloxy
- steroids
- hydroxy
- preparation
- Prior art date
Links
- 150000003431 steroids Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1717962 | 1962-04-28 | ||
| JP1718262 | 1962-04-28 | ||
| JP1717862 | 1962-04-28 | ||
| JP2774762 | 1962-07-06 | ||
| JP375763 | 1963-01-26 | ||
| JP375663 | 1963-01-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK111748B true DK111748B (da) | 1968-10-07 |
Family
ID=27547794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK197363A DK111748B (da) | 1962-04-28 | 1963-04-27 | Fremgangsmåde til fremstilling af 3β-hydroxy- eller -acyloxy-Δ<5(10)>-steroider. |
Country Status (4)
| Country | Link |
|---|---|
| CH (1) | CH500962A (da) |
| DE (1) | DE1468637A1 (da) |
| DK (1) | DK111748B (da) |
| SE (1) | SE317372B (da) |
-
1963
- 1963-04-26 CH CH420167A patent/CH500962A/de not_active IP Right Cessation
- 1963-04-27 DE DE19631468637 patent/DE1468637A1/de active Pending
- 1963-04-27 DK DK197363A patent/DK111748B/da unknown
- 1963-04-29 SE SE468563A patent/SE317372B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE1468637A1 (de) | 1969-01-02 |
| CH500962A (de) | 1970-12-31 |
| SE317372B (da) | 1969-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK115403B (da) | Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidiner. | |
| DK111956B (da) | Fremgangsmåde til fremstilling af 3,5-dioxo-17β-hydroxy-4,5-seco-Δ<9>-estren. | |
| DK105157C (da) | Fremgangsmåde til fremstilling af Δ<1,4>-16-α-metylsteroider. | |
| DK104675C (da) | Fremgangsmåde til fremstilling af 3-hydroxy-N-nitro-picolinamid. | |
| DK104346C (da) | Fremgangsmåde til fremstilling af 6-metylen-3-oxo-Δ<4>-steroider. | |
| DK111447B (da) | Fremgangsmåde til fremstilling af 17α-vinyl-5(10)-østren-17β-ol-3-on. | |
| DK111487B (da) | Fremgangsmåde til fremstilling af 17β-hydroxy- eller 17β-alkanoyloxy-3-keto-Δ<4,8(14),9>-gonatriener. | |
| DK103476C (da) | Fremgangsmåde til fremstilling af 2-oxa-3-oxo-steroider. | |
| DK109329C (da) | Fremgangsmåde til fremstilling af Δ<4>-6α-alkyl-19-nor-pregnener. | |
| DK106090C (da) | Fremgangsmåde til fremstilling af 3-halogen-Δ<5>-19-nor-androstener. | |
| DK111748B (da) | Fremgangsmåde til fremstilling af 3β-hydroxy- eller -acyloxy-Δ<5(10)>-steroider. | |
| DK103512C (da) | Fremgangsmåde til fremstilling af 3-nitroso-2-oxazolidon. | |
| DK108915C (da) | Fremgangsmåde til fremstilling af 21-acyloxy-acetyloxy-corticosteroider. | |
| DK105401C (da) | Fremgangsmåde til fremstilling af 3-oxo-Δ<4>-6-methyl-steroider. | |
| DK104786C (da) | Fremgangsmåde til fremstilling af 6-methyl-3-oxo-Δ<4,6>-steroider. | |
| DK104065C (da) | Fremgangsmåde til fremstilling af 3-phenylgranaten-(2)-derivater. | |
| DK105336C (da) | Fremgangsmåde til fremstilling af 3-oxo-17-hydroxy-13β-alkyl-Δ<5(10)>-gonener. | |
| DK112380B (da) | Fremgangsmåde til fremstilling af 6-methyl-3-oxo-Δ<4,7>-steroider af pregnanrækken. | |
| DK104063C (da) | Fremgangsmåde til fremstilling af 4-hydroxy-5-halogenpyrimidiner. | |
| DK113647B (da) | Fremgangsmåde til fremstilling af 2-sulfanilamido-5-metoxypyrimidin. | |
| DK116997B (da) | Fremgangsmåde til fremstilling af Δ<17(20)>-pregnener. | |
| DK99307C (da) | Fremgangsmåde til fremstilling af 3-oxo-10β-methyl-13β-n-propyl-Δ<4,9(11)>-steroider. | |
| DK117067B (da) | Fremgangsmåde til fremstilling af Δ<4>-3-ketosteroider. | |
| DK97077C (da) | Fremgangsmåde til fremstilling af 4-hydroxy- eller 4-acyloxy-3-keto-Δ<4>-steroider. | |
| DK96177C (da) | Fremgangsmåde til fremstilling af 4-flour-3-keto-Δ<4>-steroider. |